Enleofen Bio is a biotech company focused on developing first-in-class antibody therapeutics for treating fibrotic human diseases. Founded as a spin-off from National Heart Centre Singapore, SingHealth, and Duke-NUS Medical School, we have secured Series A funding to translate research findings into...See more
Headquarters:
Singapore
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2017 (9 years)
Address:
160 ROBINSON ROAD; SBF CENTER, #23-02; SINGAPORE, SINGAPORE 068914, SG
At a glanceThe company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
LOW
spending power
